- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Dabrafenib; trametinib – November 2015
Dabrafenib: capsule, 50 mg & 75 mg, Tafinlar® and Trametinib: tablet, 500 microgram & 2 mg, Mekinist®
Last updated
4 March 2016